Back to results
US 10,946,048 B2Granted
Use of gram negative species to treat atopic dermatitis
AssigneeThe United States of America, as represented by the Secretary, Department of Health and Human Services
InventorsIan Antheni Myles, Sandip K. Datta
Life of this patent
Estimating the term…
Abstract
Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
Claims12
A kit, comprising:
- a) a first container comprising a pharmaceutical composition, wherein the pharmaceutical composition comprises at least one strain of Roseomonas mucosa isolated or propagated from skin of a donor subject, wherein the at least one strain of Roseomonas mucosa is a viable, commensal organism and present in an amount sufficient for reducing growth of Staphylococcus aureus on skin of a subject in need thereof, and wherein the pharmaceutical composition is lyophilized;
- and
- b) instructions for reconstituting the pharmaceutical composition for topically applying to the skin of the subject.
Dependencies are inferred from the claim text.